Stock AnalizConcentra Group Holdings Parent, Inc. CON
Medical Specialities · IPO 2024 · data as of November 13, 2026
Concentra Group Holdings Parent, Inc. (CON) is a healthcare company listed in the US with a market value of about $5.3B. In the twelve months to September 30, 2026 it had revenue of $2.3B and net income of $212M, a net margin of 9.1%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is value (0/5).
Key numbers: a P/E of 25.2, a price to free cash flow of 20.8, a 5-year average ROIC of 14%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 31% below the current price.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- 5-year average ROIC above 12%
- ROE above 15%
- Positive free cash flow
- Pays a dividend
- 20% to 100% of free cash flow returned to shareholders
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 4 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.2B | $1.9B | $1.8B | $1.7B |
| Net income | $212M | $166M | $167M | $180M | $167M |
| Free cash flow | $257M | $197M | $210M | $169M | $228M |
| EPS (diluted) | $1.69 | $1.30 | $1.46 | $1.73 | $1.60 |
| Net margin | 9.1% | 7.7% | 8.8% | 9.8% | 9.7% |
| ROIC | — | 10.3% | 10.2% | 13.8% | 20.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 10 analysts is $45.90, 8% above the current price; targets range from $40.00 to $51.00; the consensus rating is “Strong buy”; expected EPS is $1.72 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Concentra Group Holdings Parent’s P/E ratio?
About 25.2, based on the last twelve months of diluted earnings per share (forward P/E about 25.1).
Is Concentra Group Holdings Parent stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 31% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Concentra Group Holdings Parent pay a dividend?
Yes. The dividend yield is about 0.59%, and it has paid dividends for 2 years in our data.
Is Concentra Group Holdings Parent a good stock to buy?
We do not give buy or sell advice. Concentra Group Holdings Parent scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.